Entry to the us
Brill announces entry into the US pharmaceutical market starting with new disruptive medical device in ophthalmology of its own development Miami, FL, April 2nd 2024 –
Brill announces entry into the US pharmaceutical market starting with new disruptive medical device in ophthalmology of its own development Miami, FL, April 2nd 2024 –
BRILL ANNOUNCES ENTRY INTO THE US PHARMACEUTICAL MARKET STARTING WITH NEW DISRUPTIVE MEDICAL DEVICE IN OPHTHALMOLOGY OF ITS OWN DEVELOPMENT Miami, FL, April 2nd
May 26, 2020 Sonoma Pharmaceuticals Announces Expanded Distribution Agreement with Brill International S.L. for Europe and approval of new CE Marking for Microdacyn60® Eye Care
Focused on developing disruptive ophthalmic solutions and determined to make a significant impact on patients´lives.
Copyright 2024, BRILL. All rights reserved. Privacy Policy